A pharmaceutical company focused on developing products which can provide improved efficacy, safety or patient convenience in the treatment of acute and chronic pain and pain related conditions.
The best Bull and Bear pitches based on recency and number of recommendations.
Aquired US rights to arthritis treatment Vimovo from Asta Zeneca Surged 32% it will recieve a 10% royalty from Horizon as part of the deal. Horizan with a full-year rev. in the range of $190 M - $205 M
Read the most recent pitches from players about POZN.DL.
Find the members with the highest scoring picks in POZN.DL.
See what the Wall Street professionals think, according to their public statements and filings.